The development of a protective vaccine against the sexually transmitted disease caused by Chlamydia trachomatis may prevent complications associated with insidious infection. Vaccination via the vaginal route may not be practical, and other routes should be investigated. To this end, the adhesion molecules induced on the fallopian tube endothelium during infection with C. trachomatis were characterized. Adhesion molecules were identified in fallopian tube biopsy specimens cultured with infection-forming units of C. trachomatis serovar E. 6 5 ϫ 10 Frozen sections were prepared from these tissues and were stained by immunohistochemical techniques. Infection with live, but not UV-inactivated, C. trachomatis induced a significant increase in levels of vascular cell adhesion molecule-1 and the mucosal addressin cell adhesion molecule-1 but not of other adhesion molecules. Therefore, infection with C. trachomatis induces adhesion molecules that are associated with other mucosal tissues and inflammatory sites, which suggests that mucosal routes of immunization may be effective.
logic responses are unclear. Thus, before a safe and effective vaccine can be designed, more information is needed about the immune response that occurs within the female genital mucosa in response to chlamydial infection.
Lymphocytes are normally present is small percentages within the endometrium and fallopian tubes and increase in number during endometriosis [7] and salpingitis [8] . Similarly, the number of lymphocytes in the endocervix increases during sexually transmitted infection with Neisseria gonorrhoeae or C. trachomatis [9] . Data from animal models of chlamydial genital infection show that T cells are temporarily recruited to the local genital mucosa in response to infection [10, 11] . Lymphocyte recruitment to the Chlamydia-infected GT are correlated with the expression of adhesion molecules on the local endothelium [12] . Endothelial cell adhesion molecules (ECAMs) mediate extravasation of lymphocytes from the circulation [13] . The unique pattern of ECAM expression is tissue specific but is also influenced by the pathogen [14] . In addition, such cytokines as tumor necrosis factor (TNF)-a, IL-1, and IL-6, which are secreted in response to many bacterial infections, induce the expression of ECAMs. Since the recruitment of lymphocyte subsets is regulated, in part, by which set of adhesion molecules appear on the endothelium, expression of adhesion molecules induced on the fallopian tube endothelium during chlamydial infection would play a substantial role in regulating lymphocyte recruitment.
Kelly and Rank [10] and Perry et al. [15] have examined the temporal expression of ECAMs in the murine GT infected with the mouse pneumonitis biovar of C. trachomatis (MoPn). Kelly and Rank [10] found that vascular cell adhesion molecule-1 (CD106) and mucosal vascular addressin cell adhesion molecule-1 (MAdCAM-1) were not expressed in the uninfected GT but were up-regulated during chlamydial infection. In contrast, intracellular cell adhesion molecule-1 (CD54) was detected in uninfected tissues and up-regulated during infection. Perry et al. [15] reported similar findings, except that MAdCAM-1 was not found in the infected GT. However, subsequent studies from this group noted the expression of MAdCAM-1 in the upper GT [13] . Taken together, the animal model studies show that adhesion molecules associated with inflammation (CD106) and the intestinal mucosae (MAdCAM-1) are induced in the genital mucosa during chlamydial infection.
Little information is available regarding ECAM expression in the human female reproductive tract. A few studies have examined endometrial tissues [16, 17] , but none have examined fallopian tube tissue or the effect of infection with C. trachomatis. Our objective in this study was to determine whether these molecules are induced on the endothelium in human fallopian tubes infected in vitro with C. trachomatis. In addition, we wanted to characterize the pattern of ECAM expression, in particular MAdCAM-1 expression. This ECAM is primarily restricted to the gut mucosa [18] and, if detected, would provide a link between the GT and other mucosal surfaces, with implications for future vaccine designs.
Methods

Antibodies.
The following mouse antihuman antibodies were purchased from PharMingen: anti-C. trachomatis lipopolysaccharide (LPS; clone CHL-888), anti-MUC1 (clone HMPV), anti-CD34 (clone 581), anti-CD54 (clone HA58), anti-CD106 (clone 51-10C9), anti-P-selectin (clone AK-4), and anti-E-selectin (clone 68-5H11); MOPC-21 served as an irrelevant control antibody. Anti-human MAdCAM-1 was a gift of Millennium Pharmaceuticals.
Human fallopian tube organ culture model. The human fallopian tube organ culture model has been described elsewhere [19, 20] . In brief, tubal specimens were harvested during abdominal hysterectomy and were washed in Hanks' balanced salt solution (Gibco BRL). Only anatomically normal fallopian tubes from surgeries for benign gynecologic diseases were used. The fallopian tube was opened longitudinally, and 4-mm punch biopsy specimens were taken from the lumen. The resultant tubal segments were placed in a 24-well tissue culture plate (Corning) and were covered with Eagle minimal essential medium containing Earle's salts and Lglutamine with colistin (3 pg/mL) and vancomycin (5 pg/mL; Gibco BRL). The segments were incubated for 24 h at 37ЊC in 5% carbon dioxide. The following day the segments were washed free of the antibiotic-containing medium. Tubal segments were inoculated with 50 mL of infection-forming units/mL C. trachomatis 8 1 ϫ 10 serotype E/UW-5/CX. Sham-inoculated segments received media only without viable bacteria. Chlamydiae that were inactivated by exposure to UV light also were used, to serve as an additional control group. Four different treatment groups were studied: 72-h sham inoculated, 72-h UV inactivated, 48-h live bacteria, and 72-h live bacteria. For some fallopian tube specimens, segments were snap frozen as described below and served as a "0-h" control. Also, for some fallopian tubes, additional segments were available and were used as 96-h specimens. Specimens were collected from 11 surgeries.
Immunohistochemistry. Fallopian tube segments were snap frozen in freezing medium (OCT; Fisher Scientific). Frozen sections (5 mm) were prepared and fixed in acetone, washed in PBS, and incubated in methanol:H 2 O 2 for 30 min. Tissue biotin sites were blocked by the addition of avidin followed by biotin. After a tissueblocking step with goat serum, the primary antibodies listed above were incubated on the tissue section for 45 min at room temperature in a humidified chamber and then were washed. A goat anti-mouse or -rabbit IgG F(ab )2 antibody conjugated to biotin (BioSource International), followed by streptavidin conjugated to horseradish peroxidase (Zymed), then was added and was incubated for 45 min. The bound enzyme was visualized with a metal-enhanced diaminobenzidine substrate (Pierce Chemical) and preserved with crystal mount (Fisher Scientific). The numbers of positive-staining venules and total venules were counted on the entire section and expressed per ϫ20 field. At least 100 fields from 3 or 4 individual biopsy specimens were analyzed for each data set. Images were collected with a color video camera (Sony Electronics).
Cytokine assays. Tissue culture supernatants were collected at the end of the treatment period and were frozen at Ϫ30ЊC. These supernatant specimens later were analyzed for IL-1b and IL-6 by ELISA (Biosource International). The 0-and 96-h specimens were not analyzed by ELISA.
Statistics. Statistical differences between treatment groups of stained fallopian tube sections were determined by analysis of variance (ANOVA), using Dunn's post hoc test (nonparametric) or Student's t test. Cytokine concentrations from the ELISAs were analyzed by 2-way ANOVA and Tukey's post hoc test. Significance was defined as . P ! .05
Results
Induction of adhesion molecules on fallopian tube endothelial cells in vitro.
By using the in vitro fallopian tube culture method described by Cooper et al. [19] , we characterized the induction of endothelial cell adhesion molecules after infection with C. trachomatis serovar E. As shown in figure 1 , we detected the presence of chlamydial inclusions within epithelial cells of fallopian cultures 48 h after infection (figure 1A, arrow). No inclusions were detected in uninfected tissues (figure 1B). We confirmed that the inclusions were localized to epithelial cells by staining with an antibody against the mucin glycoprotein, MUC1 ( figure 1C, arrow) .
Consecutive fallopian tube sections from infected and uninfected tissues were stained for various adhesion molecules, as shown in figure 2. Of the adhesion molecules belonging to the immunoglobulin superfamily (CD54, CD106, and MAdCAM-1), only CD54 was found in uninfected tissues, in which it was confined to endothelial cells ( figure 2A, arrow) . Endothelial cells were identified by staining with antibodies against the pan endothelial cell marker CD34 (data not shown). After infection with C. trachomatis, endothelial cells also expressed CD106 and MAdCAM-1 ( figure 2D and 2F, arrow) . Thus, infection with 
C. trachomatis induced the expression of ECAMs within fallopian tube tissues.
To characterize the expression of ECAMs within fallopian tube tissues during C. trachomatis infection, we quantified the response by counting the number of venules expressing ECAMs at various times after infection. As shown in figure 3, we found a significant increase in venules expressing MAdCAM-1 and CD106 by 72 h after infection. The response was diminished by 96 h. We also noted increased numbers of venules expressing CD54. However, this increase was not significant, most likely due to the presence of CD54 on venules in uninfected tissue.
The selectin family of adhesion molecules also is important for regulating the migration of lymphocytes. In particular, Pselectin (CD62P) and E-selectin (CD62E) are associated with Th1-dominated immune responses [21] . We found that both CD62P and CD62E were expressed on a limited number of endothelium-lined venules in uninfected fallopian tube tissues (figure 4). Although slight increases in the number of CD62P-positive venules was noted after infection, the increase was not significant. Thus, infection with C. trachomatis induced the selective increase in adhesion molecules from the immunoglobulin superfamily but not selectins on the fallopian tube endothelium.
The induction of ECAMs is mediated through inflammatory cytokines such as IL-1b, IL-6, and TNF-a [22] and by bacterial components, such as LPS [23] . To determine whether any surface components of C. trachomatis elementary bodies could induce ECAMs, we treated fallopian tube cultures with UVinactivated C. trachomatis. As shown in figure 5 , UV-inacti- vated C. trachomatis did not significantly induce the up-regulation of CD106, MAdCAM-1, CD54, CD62E, or CD62P, when compared with mock-infected cultures. CD34 is a marker of endothelial cells and was not expected to change during infection. These data show that surface components, such as chlamydial LPS, are not sufficient to induce the up-regulation of CD106 and MAdCAM-1.
On the basis of our findings, it seems likely that the induction of ECAMs within fallopian tube tissues during C. trachomatis infection is mediated via cytokine induction. We previously showed that TNF-a is produced within fallopian tube cultures after infection with C. trachomatis [20] . To further evaluate the role of cytokines in adhesion molecule induction, we also analyzed tissue culture supernatants from infected fallopian tube cultures for IL-1b and IL-6. Levels of both cytokines were significantly increased after infection with live C. trachomatis, compared with mock cultures (figure 6). The infection produced higher levels of IL-6 than of IL-1b. Finally, incubation with UV-inactivated C. trachomatis did not result in a significant increase in either IL-1b or IL-6. Therefore, exposure of fallopian tube tissue to viable but not UV-inactivated C. trachomatis induced secretion of IL-1b and IL-6.
Discussion
The expression of particular patterns of ECAMs is important for regulating lymphocyte migration into different tissues. This has been shown definitely by the association of MAdCAM-1 and lymphocyte migration to intestinal tissue [13] . Expression of ECAMs is dependent on the type of tissue but can be modified by cytokines [24] and bacterial components [14, 23] . Since the ability to recruit antichlamydial T cells to the infected GT will influence the outcome of a chlamydial genital infection, it is important to define ECAM expression in this setting. In our in vitro fallopian tube model, MAdCAM-1 and CD106 were induced by infection with live but not UV-inactivated C. trachomatis serovar E. This is a novel observation, and we believe that this report is the first to characterize ECAM expression on human fallopian tube tissue and the first to show MAdCAM-1 expression within the human genital mucosa. In prior studies, MadCAM-1 was not found in normal uterine tissue [16, 25] . Finally, we also found that the induction of CD106 and MAdCAM-1 is associated with the production of inflammatory cytokines, such as TNF-a, IL1b, and IL-6, after infection but not through exposure to surface components of chlamydial elementary bodies. Taken together, these data indicate that CD106 and MAdCAM-1 are induced within the human fallopian tube endothelium by live infection with C. trachomatis.
We previously characterized the expression of ECAMs in the oviducts of mice after a genital infection with MoPn. CD106 and MAdCAM-1 also were found in oviducts later in the course of MoPn infection [10, 12, 13] . These molecules were not present in any region of the GT of uninfected mice. We also detected a significant increase in CD54 expression in the oviducts during infection. However, CD54 was not found in the oviducts of uninfected mice. Although we stained fallopian tube tissues collected after surgery, it is possible that cytokines released during the hysterectomy modified CD54 expression before snap freezing of the tissue. Despite these differences, CD106 and CD54 were found on the greatest number of venules in human and mouse tissues, in comparison with other ECAMs. These findings support the use of the murine MoPn model for study of lymphocyte migration during chlamydial infection.
The selectin family members CD62P and CD62E are important for the migration of Th1 cells to sites of inflammation [21] . In the mouse model of chlamydial genital infection, Th1-type CD4 cells are necessary to eradicate infection [3] . As expected, we found that the ligand for CD62P, PSGL-1 [26] , is expressed at high levels on a Chlamydia-specific CD4 Th1 clone that migrates to the GT and eradicates infection in mice. As observed with most other ECAMs, CD62P was not detected in the oviducts of uninfected mice but was induced after MoPn infection in vivo (K.A.K., unpublished data). Surprisingly, in this study, we noted relatively few CD62P staining venules in uninfected tissues and only slight increases after infection. This difference may be due to the in vitro system used in this study. CD62P is not induced by TNF-a, IL-1b, or LPS on human endothelial cells, because of the absence of NF-kB binding sites in the human CD62P promoter [27] . However, IL-6 can induce the expression of CD62P on endothelial cells when complexed to IL-6Ra. Human endothelial cells lack IL-6Ra, but sufficient levels can be released from neutrophils to stimulate endothelial cells [28] . Thus, CD62P may be important for regulating lymphocyte migration in humans in vivo.
Of interest, incubation of fallopian tube cultures with UVinactivated serovar E did not induce a significant increase in ECAMs. LPS stimulates most ECAMs through the NF-kB signaling pathway [22] . Although chlamydial LPS stimulates the release of TNF-a from mononuclear cells, it was 100-fold less stimulatory in comparison with LPS from Salmonella species [29] . The data from this study suggest that the concentration of chlamydial LPS present on chlamydial elementary bodies is not sufficient to induce the secretion of inflammatory cytokines or expression of ECAM-1. Similarly, Kaukoranta-Tolvanen et al. [30] reported that UV-inactivated C. pneumoniae elementary bodies were less efficient at inducing CD62E, CD54, or CD106 expression on endothelial cells. These data indicate that chlamydial LPS or other molecules that are present on the surface of chlamydiae are not sufficient to induce ECAM expression.
Expression of ECAMs can be induced directly by bacterial LPS or through the cytokines TNF-a, IL-1b, and IL-6. We reported previously that TNF-a is produced in this model of human GT infection [20] . In this report, we also show that IL-1b and IL-6 are produced by human fallopian tube tissues infected with C. trachomatis. We speculate that the infected tubal epithelium is the source of these cytokines, because epithelial cells were the source of TNF-a production [20] . Also, Rasmussen et al. [31] found that primary endocervical cells infected with chlamydiae produced both IL-1b and IL-6. All 3 of these cytokines can induce ECAM expression and appear to be important for induction of ECAMs within C. trachomatis-infected fallopian tubes.
Perhaps our most important finding is the expression of MAdCAM-1 in the infected fallopian tube. Other researchers have examined human uterine tissues in the absence of infection and did not detect MAdCAM-1 expression [16, 25] . Likewise, we found that MAdCAM-1 expression was not readily detected in uninfected tissues. MAdCAM-1 is necessary for the trafficking of lymphocytes into intestinal tissues [13] . We recently showed that blocking the ligand for MAdCAM-1, a4b7, which is expressed on lymphocytes, inhibits the ability of protective Chlamydia-specific CD4 clone cells to migrate to the GT in vivo during infection [32] . Taken together, these findings suggest that, during infection with C. trachomatis, intestinal lymphocytes could migrate to fallopian tube tissues through a4b7: MAdCAM-1 interactions. We are currently testing this possibility, to determine whether oral vaccination may be a viable mode of vaccine delivery for protection against sexually transmitted C. trachomatis infections.
